Similar Search Results

Does the crowd-out effect of R&D subsidies exist in the pharmaceutical industry? : evidence from Chinese companies

Ni, Kejin - In: Modern economy 11 (2020) 3, pp. 645-656

Persistent link: https://www.econbiz.de/10012501487

The potential of industrial agglomeration to promote pharmaceutical innovation : analysis of China's "medicine valley" construction upsurge

Fan, Jianting; Zhao, Fusen; Zhao, Yuhao - In: China & world economy 30 (2022) 6, pp. 86-112

Persistent link: https://www.econbiz.de/10013472471

India-Pakistan trade : an analysis of the pharmaceutical sector

Pant, Manoj; Pande, Devyani - 2014

With the ongoing trade normalisation process between India and Pakistan, opportunities to integrate have opened up between both countries. The pharmaceutical sector is crucial to health issues in developing economies and would be an ideal segment to focus on in improving trade relations between...

Persistent link: https://www.econbiz.de/10010404687

The limits to upgrading and value capture in R&D global value chains : Indian and Chinese contract R&D firms in the integrated circuit design and pharmaceutical global value chains

Fuller, Douglas B.; Ramirez, Paulina - In: Competition & change : the journal of global business … 28 (2024) 1, pp. 144-164

Persistent link: https://www.econbiz.de/10014631324

Proceedings of the Workshop on the Pharmaceutical Industry (Combined Modern-Traditional Pharmacy) for Promoting Technical Co-operation among the Developing Countries : Beijing and...

1985

Persistent link: https://www.econbiz.de/10000752237

Pharmaceutical policy in China

Sun, Qiang; Santoro, Michael A.; Meng, Qingyue; Liu, Caitlin - In: Health affairs : at the intersection of health, health … 27 (2008) 4, pp. 1042-1050